期刊文献+

临床药师对肿瘤患者的药学监护 被引量:4

Clinical Pharmacists' Experience of Pharmaceutical Care for Cancer Patients
下载PDF
导出
摘要 目的:探讨临床药师对肿瘤患者实施药学监护的切入点。方法:针对典型案例,临床药师从药物治疗方案的选择、药物相互作用、药物用法与用量、溶剂、用药时间及药品不良反应监测等方面提供药学服务。结果与结论:临床药师是医师、护士和患者之间的桥梁,是治疗团队中的一员。临床药师只有深入临床,在实践工作中不断地总结和探索,才能切实做好临床药学服务工作。 OBJECTIVE:To explore entry points for pharmacists to carry out pharmaceutical care for cancer patients.METHODS: Aimed at type cases, pharmacists carried out pharmaceutical care for cancer patients from aspects of choice of pharmacotherapy , drug interaction, dosage and administration , solvents, medication time and monitoring of adverse drug reactions etc .RESULTS & CONCLUSIONS: Clinical pharmacist , as one member of treatment team, serves as a bridge between physicians/nurses and patients.Clinical pharmacists can only provide proper pharmaceutical care through gathering experience and exploring in clinical practice .
出处 《中国医院用药评价与分析》 2015年第1期134-136,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 临床药师 肿瘤患者 药学监护 Clinical pharmacist Cancer patient Pharmaceutical care
  • 相关文献

参考文献15

二级参考文献101

  • 1闫桂环,洪莹彬.静点碳酸氢钠的时间对减轻环磷酰胺肾脏毒性的效果观察[J].中国实用护理杂志(下旬版),2005,21(2):3-4. 被引量:7
  • 2杨梅,汤致强.肿瘤时辰治疗的研究与探索[J].中国新药杂志,2006,15(21):1807-1812. 被引量:6
  • 3李家泰.临床药理学[M].北京:人民卫生出版社,1998.741-742.
  • 4Wittkowsky AK. Warfarin and other coumarin derivatives: phannacokinetics, pharmacodynamics, and drug interactions[J]. Semin Vasc Med, 2003, 3 (3) : 221-230.
  • 5Kolesar JM, Johnson CL, Freeberg BL, et al. Warfarin-5-FU interaction--a consecutive case series [ J]. Pharmacotherapy, 1999, 19 (12): 1445-1449.
  • 6Copur MS, Ledakis P, Bohon M, et al. An adverse interaction between warfarin and capecitabine: a case report and review of the hterature[J]. Clin Colorectal Cancer, 2001, 1 (3): 182-184.
  • 7Buyck HC, Buckley N, Leslie M D, et al. Capecitabineinduced potentiation of warfarin [ J ]. Clin Oncol ( R Coil Radiol) , 2003, 15 (5) : 297.
  • 8Isaacs K, Haim N. Adverse interaction between capecitabine and warfarin resulting in altered coagulation parameters and bleeding: case report and review of the literature [J]. J Chemother, 2005, 17(3) : 339-342.
  • 9Yildirim Y, Ozyilkan O, Akcali Z, et al. Drug interaction between capecitabine and warfarin: a case report and review of the literature [ J]. Int J Clin Pharmacol Ther, 2006, 44 (2) : 80-82.
  • 10Camidge R, Reigner B, Cassidy J, et al. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer [ J ]. J Clin Oncol, 2005, 23(21 ): 4719-25.

共引文献83

同被引文献35

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部